Volume 14 Supplement 1
6th International Conference on cGMP: Generators, Effectors and Therapeutic Implications
Meeting abstracts
Edited by John C Burnett Jr, Franz Hofmann, Kazuwa Nakao, Harald HHW Schmidt and Johannes-Peter Stasch
Publication of this supplement has been fully funded by Bayer Pharma AG. Johannes-Peter Stasch is an employee of Bayer Pharma AG, Wuppertal, Germany. He holds many patents on sGC stimulators and sGC activators. John C Burnett Jr is the chairman of the advisory board for Nile Therapeutics and is a Co-Founder and the Chief Scientific Officer for Zumbro Discovery. Mayo Clinic has licensed CD-NP to Nile Therapeutics and MANP to Zumbro Discovery. The other Supplement Editors declare that they have no competing interests.
6th International Conference on cGMP: Generators, Effectors and Therapeutic Implications. Go to conference site.
Erfurt, Germany28-30 June 2013
Page 3 of 3
-
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P63
-
Endothelial dysfunction in a mouse model of human neutral lipid storage disease
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P64 -
Discovery of neuroprotective soluble guanylate cyclase modulators (GCMs) aciting via NO/GC/cGMP/CREB pathway
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P65 -
Genetic silencing of sGC β1 in cancer: role of epigenetic regulation
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P66 -
Krait natriuretic peptide (KNP): a non-classical NP
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P67 -
Cardiac cGMP/cGMP-dependent protein kinase I signalling requires cysteine-rich LIM-only protein 4 (CRP4) to oppose angiotensin II induced hypertrophy and fibrosis
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P68 -
Differential regulation of platelet inhibition by cGMP- and cAMP-dependent protein kinases
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P69 -
Linaclotide induces secretion of cGMP from mouse colonic epithelium
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P70 -
Receptor guanylyl cyclase B-mediated cGMP signalling controls axon bifurcation of cranial sensory ganglion neurons at the embryonic hindbrain
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P71 -
NO/cGMP/pCREB re-activation reverses cognition deficits and attenuates amyloid-β neuropathology in transgenic models of Alzheimer’s disease
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P72 -
Endothelial GC-A can be a therapeutic target for metabolic syndrome
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P73 -
Phospho-specific antisera to monitor N-terminal autophosphorylation of cGMP-dependent protein kinase type I
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P74 -
The soluble guanylate cyclase activator BAY 58-2667 protects against morbidity and mortality in endotoxic shock by recoupling organ systems
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P75 -
Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P76 -
Genes involved in pulmonary hypertension of mice with endothelial-specific ablation of guanylyl cyclase A
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P77 -
Identification of cCMP binding and activated proteins
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P78 -
Activation profile of cGMP-dependent protein kinase Iα
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P79 -
Anti-interleukin-6 therapy for treatment of high platelet counts in cGMP-dependent protein kinase I gene-targeted mice
Citation: BMC Pharmacology and Toxicology 2013 14(Suppl 1):P80
Annual Journal Metrics
-
Speed
42 days to first decision for all manuscripts
77 days to first decision for reviewed manuscripts only
192 days from submission to acceptance
17 days from acceptance to publicationCitation Impact
2.483 - 2-year Impact Factor
2.806 - 5-year Impact Factor
1.084 - Source Normalized Impact per Paper (SNIP)
0.618 - SCImago Journal Rank (SJR)Usage
588,461 Downloads (2021)
97 Altmetric Mentions
Peer-review Terminology
-
The following summary describes the peer review process for this journal:
Identity transparency: Single anonymized
Reviewer interacts with: Editor
Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication